Dianthus Therapeutics (DNTH) PT Raised to $125 at Oppenheimer
Tweet Send to a Friend
(Updated - January 29, 2026 6:04 AM EST)
Oppenheimer analyst Trevor Allred raised the price target on Dianthus Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Trevor Allred raised the price target on Dianthus Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
